Maze Therapeutics, Inc 10-K for FY2025
Maze Therapeutics, Inc. (MAZE)
10-K
2026-03-25
For: 2025-12-31
View Original
Added on
April 07, 2026
About this 10-K
Maze Therapeutics, Inc filed this 10-K on March 25, 2026, covering the fiscal year ended December 31, 2025 (FY2025).
Headline figures
Fiscal year ended December 31, 2025, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Net loss
- $131.12M
- compared with net income of $52.23M a year earlier
- Diluted EPS
- -$3.05
- compared with $1.25 a year earlier